Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Sieber

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Seminars in Cancer Biology|December 23, 2004
Genomic stability and tumorigenesisOliver Sieber, Karl Heinimann, Ian Tomlinson
The Journal of Pathology|January 21, 2003
Colorectal tumourigenesis in carriers of the APC I1307K variant: lone gunman or conspiracy?Oliver Sieber, Lara Lipton, Karl Heinimann, et al.
Human Molecular Genetics|September 11, 2004
An update on the genetics of colorectal cancerZoe Kemp, Cristina Thirlwell, Oliver Sieber, et al.
Journal of Medical Genetics|May 15, 2007
Pregnancy does not influence colonic polyp multiplicity but may modulate upper gastrointestinal disease in patients with FAPNirosha Suraweera, Andrew Latchford, Amy McCart, et al.
Molecular Cancer Research : MCR|May 3, 2015
Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal CarcinogenesisDane Cheasley, Lloyd Pereira, Shienny Sampurno, et al.
Genome Biology|September 23, 2010
A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping dataChristopher Yau, Dmitri Mouradov, Robert N Jorissen, et al.
Cancer|April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerBen Tran, Scott Kopetz, Jeanne Tie, et al.
Cancer Research|December 17, 2005
CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instabilityZoe Kemp, Andrew Rowan, William Chambers, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2025
<i>SRP19</i> and the protein secretion machinery is a targetable vulnerability in cancers with <i>APC</i> lossXinqi Xi, Ling Liu, Natasha Tuano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Seminars in Cancer Biology|December 23, 2004
Genomic stability and tumorigenesisOliver Sieber, Karl Heinimann, Ian Tomlinson
The Journal of Pathology|January 21, 2003
Colorectal tumourigenesis in carriers of the APC I1307K variant: lone gunman or conspiracy?Oliver Sieber, Lara Lipton, Karl Heinimann, et al.
Human Molecular Genetics|September 11, 2004
An update on the genetics of colorectal cancerZoe Kemp, Cristina Thirlwell, Oliver Sieber, et al.
Journal of Medical Genetics|May 15, 2007
Pregnancy does not influence colonic polyp multiplicity but may modulate upper gastrointestinal disease in patients with FAPNirosha Suraweera, Andrew Latchford, Amy McCart, et al.
Molecular Cancer Research : MCR|May 3, 2015
Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal CarcinogenesisDane Cheasley, Lloyd Pereira, Shienny Sampurno, et al.
Genome Biology|September 23, 2010
A statistical approach for detecting genomic aberrations in heterogeneous tumor samples from single nucleotide polymorphism genotyping dataChristopher Yau, Dmitri Mouradov, Robert N Jorissen, et al.
Cancer|April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerBen Tran, Scott Kopetz, Jeanne Tie, et al.
Cancer Research|December 17, 2005
CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instabilityZoe Kemp, Andrew Rowan, William Chambers, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2025
<i>SRP19</i> and the protein secretion machinery is a targetable vulnerability in cancers with <i>APC</i> lossXinqi Xi, Ling Liu, Natasha Tuano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancerEnric Domingo, David N Church, Oliver Sieber, et al.
Pageof 3